2,851
edits
Line 148: | Line 148: | ||
In the clinical study, a ~20-fold increase in bioavailability was measured compared to standard quercetin with equal doses. Given that Quercetin Phytosome contains ~40% and has a ~20 fold relative bioavailability, one can assume that the total bioavailability of standard quercetin is less than 2%. | In the clinical study, a ~20-fold increase in bioavailability was measured compared to standard quercetin with equal doses. Given that Quercetin Phytosome contains ~40% and has a ~20 fold relative bioavailability, one can assume that the total bioavailability of standard quercetin is less than 2%. | ||
{| class="wikitable" | {| class="wikitable" | ||
|+Pharmacokinetic parameters | |+Pharmacokinetic parameters <ref name=":0" /> | ||
! | ! | ||
!Quercetin 500 mg | !Quercetin 500 mg |